Delivery Order SPE2DR25D1053-SPE2DR26FV702
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a firm fixed price ceiling value of $44,726.24 and ultimate completion date of January 15, 2026. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on December 16, 2025. This firm fixed price delivery order, valued at $8,386.17, represents a non-set-aside competitive award with an ultimate completion date of January 8, 2026. The pharmaceuticals will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply requirements for military and veteran...
- The Defense Logistics Agency awarded a $29,861.60 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 10, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,986.44 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 9, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $33,544.68 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,903.44 to AmerisourceBergen Drug Corp for the supply of IMFINZI (120 mg/2.4 ml vial) on October 24, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. IMFINZI is a specialized oncology pharmaceutical product, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of IMFINZI (an oncology medication) in 120 mg/2.4 mL vials with a ceiling value of $6,344.80. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $15,915.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of IMFINZI 500 mg/10 mL vials. The award, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of December 1, 2025. The contract was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV702Delivery Order
On January 21, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $44,792.40 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by February 11, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle that extends through December 31, 2031. This primary IDC enables comprehensive pharmaceutical and medical supply support to military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen Drug Corp operates as a critical vendor within the federal medical procurement ecosystem, specializing in pharmaceutical distribution to defense and military healthcare systems. As a subsidiary of Cencora, Inc., the company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions through its extensive supply network. The IMFINZI delivery supports military treatment facilities and veteran healthcare programs requiring oncology-related pharmaceutical products, consistent with the company's demonstrated track record of fulfilling federal medical supply requirements through open and competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.8k | 1/20/26 |